BFM
SAGE

Boothbay Fund Management’s Sage Therapeutics SAGE Stock Holding History

Boothbay Fund Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,384,465
Closed -$11M – 1728
2025
Q1 		$11M Sell
1,384,465
-4,038
-0.3% -$29.6K 0.29% 61
2024
Q4 		$7.54M Buy
+1,388,503
New +$8.49M 0.19% 159
2023
Q1 		– Sell
-11,601
Closed -$442K – 2456
2022
Q4 		$442K Sell
11,601
-14,812
-56% -$566K 0.01% 1222
2022
Q3 		$1.03M Buy
+26,413
New +$1.02M 0.03% 853
2022
Q2 		– Sell
-30,593
Closed -$1.03M – 2613
2022
Q1 		$1.01M Buy
+30,593
New +$1.15M 0.02% 894
2021
Q2 		– Sell
-10,621
Closed -$751K – 2078
2021
Q1 		$795K Buy
10,621
+2,957
+39% +$242K 0.03% 719
2020
Q4 		$663K Sell
7,664
-6,370
-45% -$469K 0.02% 647
2020
Q3 		$858K Sell
14,034
-10,175
-42% -$516K 0.05% 481
2020
Q2 		$1.01M Buy
24,209
+3,096
+15% +$112K 0.07% 381
2020
Q1 		$606K Sell
21,113
-1,570
-7% -$90.9K 0.05% 419
2019
Q4 		$1.64M Buy
+22,683
New +$2.79M 0.14% 196
2018
Q3 		– Sell
-2,278
Closed -$352K – 928
2018
Q2 		$357K Sell
2,278
-1,457
-39% -$229K 0.03% 429
2018
Q1 		$602K Sell
3,735
-173
-4% -$29.4K 0.07% 277
2017
Q4 		$644K Buy
+3,908
New +$379K 0.09% 203

Other funds holding SAGE

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Boothbay Fund Management's SAGE Position: Q2 2025 in Review

Boothbay Fund Management sold out of Sage Therapeutics (SAGE) in Q2 2025, closing a stake of 1,384,465 shares — an estimated $11M sold.

Boothbay Fund Management first reported a position in SAGE in Q4 2017 and held it in 14 quarters. The position peaked at $11M in Q1 2025. 191 funds tracked by Wall St. Rank hold SAGE as of Q2 2025.

  • Boothbay Fund Management reported no remaining Sage Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 1,384,465 Sage Therapeutics shares in Q2 2025, an estimated $11M.
  • Boothbay Fund Management first reported a position in Sage Therapeutics in Q4 2017 and held it in 14 quarters.
  • Boothbay Fund Management's Sage Therapeutics position peaked at $11M in Q1 2025.
  • 191 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2025.

Based on Boothbay Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.